By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
DenySELECT COOKIES
Accept

Mentice to present the company's Q2-2024 Interim Report

Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested part

July 9, 2024
Mentice

Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Ulrika Drotz.

The presentation of the Q2 Interim Report for the period April – June 2024 will be held on July 23 at 10:00 CEST. The live broadcast is followed by a Q&A moderated by Redeye’s analyst Christian Binder. For more information on how to join, please visit https://investor.mentice.com/.

The presentation will be held in English. Participants are advised to join at least a few minutes in advance.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: goran.malmberg@mentice.com
US Mobile. +1 (312) 860 5610
Sweden Mobile +46 (0) 703 09 22 22

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB

Attachments
Mentice to present the company's Q2-2024 Interim Report

Join us today

To always stay on top within the field of medical simulation and its development subscribe to our news and resource list

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

More from Mentice

Other News

Article
May 14, 2012

How Many Deaths Are Due to Medical Error? Do we have the right numbers or are we guessing?

Just over a decade ago, the patient safety movement gained strength in the United Kingdom and the United States as both countries were publically h...

read more
Mentice: Link to similar products within the neuroradiologists
Press Release 
April 20, 2023

Mentice’s CEO Göran Malmberg to present the company’s interim report at a webcast conference call on April 27 at 10:00 CEST

Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested part

read more
Mentice: Link to similar products within the neuroradiologists
Article
September 23, 2015

He faced health issues as a result of chronic, low-level exposure to ionising radiation through his work. Watch the video.

We would like to share this amazing video that brings home the message on a personal level to all users in vascular labs.

read more
Mentice: Link to similar products within the neuroradiologists
Healthcare Professionals
NeurovascularCardiovascularPeripheral VascularOnboarding, training & adoption
Medtech Industry
Research & DevelopmentSales & MarketingProfessional EducationIndustry Development Process
Angiosuite & Robotics Integrations
Operating room integrationsAngio suitesInterventional Robotics
VIRTUAL SIMULATION
Virtual Sim PlatformsLearning modules & softwareExtensions & add-onsAngiosuite integrations
Cloud & Mobile applications
Mentice LiveRight heart cath app
Real anatomical replication
Vascular Twin (case-it)
flow models
Physiological Flow SystemsExtensions and Add-onsSilicon VesselsFlow System Accessories
ANKYRAS
Braided Stent Support ApplicationTechnologyGalleryPublicationsIFU
Resources
NewsWhitepapers & ArticlesWebinarsClinical Research & PublicationsEventsGlossaryCustomer storiesOnboarding, training & adoptionDevelopment processIntellectual Property
about mentice
About MenticeInvestorsPressCareersSustainability
CONTACT US
Headquarter and Regional OfficesRegional DistributorsSupport
Device & Procedural Development
Device & Procedural DevelopmentServices
Data PolicyQuality PolicyDisclaimerTermsWhistleblower Policy
Copyright © 2024 Mentice. All rights reserved.